BLUGLASS PRESENTS ITS HALF YEAR REPORT

The BluGlass Board and Management are pleased to provide the Company’s Half Year Financial Report for the HY ending 31 December 2021.

During the half year, BluGlass continued to optimise the four key components needed to launch reliable laser diodes (epitaxy, metals, facets and bonds), strengthened the Company’s expert leadership team and demonstrated significant performance improvements across four prototypes: the 405nm and 420nm laser diodes in both single-mode and multi-mode devices. BluGlass remains on-track to launch our first direct-to-market laser diodes mid-calendar year.

Key H1 FY22 achievements:

  • Appointed veteran laser diode executive Jim Haden to lead BluGlass
  • Demonstrated world-first proof of concept of working RPCVD tunnel junction laser diodes
  • Significantly improved performance of 405nm and 420nm single-mode and multi-mode prototype devices
  • Continued progress towards delivering four key components needed for reliable laser diodes
  • Strong customer support of latest laser diode performance data at leading industry conference, Photonics West
  • Secured power electronics epitaxy foundry agreement with European wafer developer
  • On track to launch its first direct-to-market laser diodes mid-calendar year.

The full report is available to download here: BLG Appendix 4D and Half Year Report 31 December 2021

BluGlass logo
About BluGlass

Developing leading-edge semiconductor manufacturing technology and devices for more than a decade, BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.

Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the USA offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.

The Company combines its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing process with advanced device design and fabrication to deliver differentiated laser solutions. With end-to-end capabilities spanning epitaxy, device design, fabrication, and testing, BluGlass is well-positioned to support critical next-generation photonics applications and sovereign supply chains.

For more information, please contact:

Stefanie Winwood
+61293342300 |swinwood@bluglass.com
James Lennon, Automic Markets
+61414035704 |james.lennon@automicgroup.com.au
Samuel Samhan, BluGlass CFO
ssamhan@bluglass.com